Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

First-principles simulations of the fluorescence modulation of a COX-2-specific fluorogenic probe upon protein dimerization for cancer discrimination

  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • Curutchet, Carles|||0000-0002-0070-1208
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Cyclooxygenase-2 (COX-2) plays a crucial role in inflammation and has been implicated in cancer development. Understanding the behavior of COX-2 in different cellular contexts is essential for developing targeted therapeutic strategies. In this study, we investigate the fluorescence spectrum of a fluorogenic probe, NANQ-IMC6, when bound to the active site of human COX-2 in both its monomeric and homodimeric forms. We employ a multiscale first-principles simulation protocol that combines ground state MM-MD simulations with multiple excited state adiabatic QM/MM Born-Oppenheimer MD simulations based on linear response TD-DFT, which allows to account for protein heterogeneity effects on excited-state properties. Emission is then estimated from polarizable embedding TD-DFT QM/MMPol calculations. Our findings indicate that the emission shift arises from dimerization of the highly overexpressed COX-2 in cancer tissues, in contrast to the monomer structure present in inflammatory lesions and in normal cells with constitutive COX-2. This spectral shift is linked to changes in specific protein-probe interactions upon dimerization due to changes in the environment, whereas steric effects related to modulation of the NANQ geometry by the protein scaffold are found to be minor. This research paves the way for detailed investigations on the impact of environment structural transitions on the spectral properties of fluorogenic probes. Moreover, the fact that COX-2 exists as homodimer just in cancer tissues, but as monomer elsewhere, gives novel hints for therapeutical avenues to fight cancer and contributes to the development of drugs targeted to COX-2 dimer in cancer, but without affecting constitutive COX-2, thus minimizing off-target effects.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Spiranic compounds as novel AMPK paradoxical inhibitors: can we derive new mechanistic

  • Sanz-Gomez, Marta
  • Barmpidi, Katerina
  • Quesada-Sanchez, Sergio
  • Cumella, Jose
  • Perez, Concepcion
  • Sanz, Pascual
  • Doyaguez, Elisa G.
  • Infantes, Lourdes
  • Luque, Francisco Javier
  • Castro, Ana
  • Lagartera, Laura
  • Fernandez-Alfonso, Maria S.
  • Estarellas, Carolina
  • García-Gimeno, María Adelaida|||0000-0002-6483-3912
[EN] In this study, we synthesized and fully characterized spiranic compounds designed as conformationally restricted mimetics of A-769662 by means of crystallographic, spectroscopic, and computational methods. In vitro enzymatic assays and surface plasmon resonance experiments revealed a mixed-type inhibition mechanism. We developed a stable and equilibrated alpha 1(31 AMPK model featuring the A-loop in a closed conformation, which was used to investigate alternative binding pockets beyond the canonical AMPK sites, namely type II-like pocket. The cell-based and tissue experiments further demonstrated that these compounds act as paradoxical inhibitors, since it enhances downstream signalling by increasing phosphorylation of ACC and eNOS, ultimately activating the AMPK-eNOS-NO pathway and inducing vasodilation in rat aorta. Altogether, our findings offer new insights into AMPK modulation and highlight the potential of spiranic scaffolds as tools for probing alternative regulatory mechanisms., This research was supported by Fundacion Eugenio Rodriguez Pascual, the Spanish Ministerio de Economia y Competitividad [CEX2021-001202-M] , the Spanish Ministerio de Ciencia Innovacion y Universidades [PID2023-147942OB-I00, PID2022-142623OA-I00, PID2020-117400 GB-100] and the Generalitat de Catalunya [2021SGR00671] . Computational resources from the Barcelona Super-computing Center (BSC; BCV-2022-1-0014 and BCV-2023-2-0020) and the Consorci de Serveis Universitaris de Catalunya (CSUC; Molecular Recognition project) are acknowledged. M.S.G. thanks Universidad Complutense de Madrid for her fellowship. K.B. thanks Generalitat de Cataluna for FI fellowship [2023 FISDU 00519] .